stella
beta
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults — Stella
Recruiting
Back to Medulloblastoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Lucile Packard Children's Hospital Stanford, Palo Alto, California
View full record on ClinicalTrials.gov